HOLX
🚫 does not pay dividends

Company News

Hologic Goes Private In $18 Billion Blackstone, TPG Acquisition
Benzinga • Lekha Gupta • April 8, 2026

Hologic has completed its acquisition by Blackstone and TPG for approximately $18.3 billion. Shareholders receive $76 per share in cash plus a contingent value right (CVR) worth up to $3 per share tied to Breast Health business revenue milestones. The company has been delisted from Nasdaq, and José E. Almeida has been appointed as the new CEO.

Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence
GlobeNewswire Inc. • Mordor Intelligence • March 10, 2026

The global molecular diagnostics market is projected to reach USD 33.51 billion by 2031, growing at a CAGR of 10.43% from 2026 to 2031. Growth is driven by increasing adoption of precision medicine, advancements in genomic testing technologies, and rising prevalence of infectious and chronic diseases. North America leads the market while Asia-Pac...

RadNet Makes $270 Million Bet On AI Future With Gleamer Buyout
Benzinga • Akanksha Bakshi • March 2, 2026

RadNet (NASDAQ: RDNT) reported record Q4 revenue of $547.7M (up 14.8% YoY) and adjusted EBITDA of $87.7M (up 16.9% YoY), beating analyst estimates. The company announced a $270M acquisition of Paris-based AI radiology firm Gleamer to strengthen its Digital Health division. RadNet guided for 2026 imaging center revenue growth of 17-19% and digital...

Scar Treatment Market Size is Expected to Reach USD 56.30 Billion by 2033; Growth is Propelling Due to the Surging Awareness for Advanced Cosmetic and Reconstructive Procedures Globally
GlobeNewswire Inc. • Sns Insider • February 18, 2026

The global scar treatment market is projected to grow from USD 26.60 billion in 2025 to USD 56.30 billion by 2033, with a CAGR of 9.91%. Growth is driven by increasing awareness of advanced cosmetic and reconstructive procedures, rising prevalence of acne, surgical, and traumatic scars, and technological advancements in minimally invasive treatme...

Uterine Fibroid Market Size to Reach USD 9.43 Billion by 2033 with 7.63% CAGR – SNS Insider
GlobeNewswire Inc. • Sns Insider Research • February 16, 2026

The global uterine fibroid market is projected to grow from USD 5.26 billion in 2025 to USD 9.43 billion by 2033 at a CAGR of 7.63%. Growth is driven by rising prevalence of fibroids (affecting 70-80% of women by age 50), technological advances in minimally invasive procedures with 60% adoption increase, and expanded healthcare infrastructure in ...

Related Companies